Breaking News

Is WHO ready to end the Covid emergency?; substandard children's chemo drug shipped around the world

January 25, 2023
From left, Michael Ryan, Tedros Adhanom Ghebreyesus, and Maria Van Kerkhove of the WHO attend a daily Covid-19 press briefing at the organization's Geneva headquarters in March 2020, just weeks after the WHO declared a PHEIC.
FABRICE COFFRINI/AFP via Getty Images

Is WHO ready to end the global health emergency over Covid? Maybe not just yet

An emergency committee will gather as Covid rips for the first time through the world's most populous nation.

By Helen Branswell


The drug was meant to save children's lives. Instead, they're dying

Substandard asparaginase, a childhood leukemia drug, has been shipped to more than 90 countries, overwhelmingly from companies in India.

By Rosa Furneaux and Laura Margottini — TBIJ


STAT+ | The 4 biggest questions about the FDA's forthcoming changes to accelerated approvals

Congress just boosted the FDA's authority over the post-market clinical trials that are a condition of speedy drug approvals.

By John Wilkerson



A child receives a dose of Pfizer's Covid-19 vaccine at an event launching school vaccinations in Los Angeles in November 2021.
FREDERIC J. BROWN/AFP via Getty Images

Updated Covid-19 booster still providing strong protection against newer variants, CDC study finds

The protection offered by the updated Covid booster appears to be holding up against the newest Omicron subvariants.

By Helen Branswell


STAT+ | Focused exclusively on life sciences, three top investors set out on their own

Dimension, led by Zavain Dar, Adam Goulburn, and Nan Li, launched Wednesday with $350 million for its first fund.

By Allison DeAngelis


STAT+ | Vir CEO George Scangos to retire, after pandemic success

George Scangos, 74, will retire after nearly 40 itinerant years, including at Bayer and a turnaround stint at Biogen.

By Jason Mast


Mary Altaffer/AP

Opinion: Making naloxone available over the counter won't solve the overdose crisis — but it will help

Making naloxone, an overdose-reversal drug, available over-the- counter would be an important step for easing the opioid overdose crisis.

By Stacey McKenna


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Daily Recap? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
Facebook
Youtube
Twitter
Instagram
STAT, 1 Exchange Place, Boston, MA
©2023, All Rights Reserved.

No comments